Volume 68 Received 5 December 2011 | ||||||||||
| ||||||||||
-Hydroxy-4,9-dimethyl-13-(morpholin-4-ylmethyl)-3,8,15-trioxatetracyclo[10.3.0.02,4.07,9]pentadecan-14-oneabLaboratoire de Chimie Biomoléculaire, Substances Naturelles et Réactivité, URAC 16, Faculté des Sciences Semlalia, BP 2390, Bd My Abdellah, 40000 Marrakech, Morocco,bUniversite Blaise Pascal, Laboratoire des Mate'riaux Inorganiques, UMR CNRS 6002, 24 Avenue des Landais, 63177 Aubie`re, France, and cLaboratoire de Chimie Bioorganique et Analytique, URAC 22, BP 146, FSTM, Université Hassan II, Mohammedia-Casablanca 20810 Mohammedia, Morocco
Correspondence e-mail: mberraho@yahoo.fr
The title compound, C19H29NO6, was synthesized from 9
-hydroxyparthenolide (9
-hydroxy-4,8-dimethyl-12-methylene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one), which was isolated from the chloroform extract of the aerial parts of Anvillea radiata. The molecule contains a fused five- and ten-membered ring system. The ten-membered ring adopts an approximate chair-chair conformation, while the five-membered ring is in an envelope conformation, with the C atom closest to the hydroxy group forming the flap. In the crystal, weak C-H
O hydrogen bonds connect the molecules into layers parallel to (001). An intramolecular O-H
N hydrogen bond is also present.
For background to the medicinal uses of the plant Anvillea radiata, see: El Hassany et al. (2004
); Qureshi et al. (1990
). For the reactivity of this sesquiterpene, see: Hwang et al. (2006
); Neukirch et al. (2003
); Neelakantan et al. (2009
). For ring puckering parameters, see: Cremer & Pople (1975
). For the synthesis see: Moumou et al. (2010
).
|
|
|
|
Data collection: APEX2 (Bruker, 2005
); cell refinement: SAINT (Bruker, 2005
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick,2008
); program(s) used to refine structure: SHELXL97 (Sheldrick,2008
); molecular graphics: ORTEP-3 for Windows (Farrugia,1997
)and PLATON (Spek, 2009
); software used to prepare material for publication: WinGX (Farrugia, 1999
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: LH5393 ).
The authors thank the Unit of Support for Technical and Scientific Research (UATRS, CNRST) for financial support.
Bruker, (2005). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
![[ISI]](../../../../../../logos/isiborder.gif)
El Hassany, B., El Hanbali, F., Akssira, M., Mellouki, F., Haidou, A. & Barero, A. F. (2004). Fitoterapia, 75, 573-576.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.
![[details]](../../../../../../j/graphics/details.gif)
Hwang, D.-R., Wu, Y.-S., Chang, C.-W., Lien, T.-W., Chen, W.-C., Tan, U.-K., Hsu, J. T. A. & Hsieh, H.-P. (2006). Bioorg. Med. Chem. 14, 83-91.
Moumou, M., Akssira, M., El Ammari, L., Benharref, A. & Berraho, M. (2010). Acta Cryst. E66, o2395.
![[details]](../../../../../../e/graphics/details.gif)
Neelakantan, S., Nasim, Sh., Guzman, M. L., Jordan, C. T. & Crooks, P. A. (2009). Bioorg. Med. Chem. Lett. 19, 4346-4349.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Neukirch, H., Kaneider, N. C., Wiedermann, C. J., Guerriero, A. & D?Ambrosio, M. (2003). Bioorg. Med. Chem. 11, 1503-1510.
Qureshi, S., Ageel, A. M., Al-Yahya, M. A., Tariq, M., Mossa, J. S. & Shah, A. H. (1990). J. Ethnopharmacol. 28, 157-162.
![[ISI]](../../../../../../logos/isiborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)